Although our approach aimed to identify major hub genes central to MS molecular mechanisms through the combination of a vote‐counting strategy and de novo network analysis, the high cross‐study consistency of CASP1 and VIM is also noteworthy. The gene discussed is CASP1; the disease is myeloid sarcoma.